Related Experiment Video

Updated: Dec 21, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Cardiovascular disease and COVID-19: les liaisons dangereuses

Andrea Barison1,2, Alberto Aimo2,3, Vincenzo Castiglione2,3

  • 1Cardiology Division, Fondazione Toscana Gabriele Monasterio, Italy.

European Journal of Preventive Cardiology
|May 12, 2020
PubMed

Insights

Patients with cardiovascular disease face higher risks from coronavirus disease 19 (COVID-19). This review examines current evidence on cardiovascular therapies and their impact on COVID-19 infection and survival, offering practical recommendations for clinicians.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Patients with cardiovascular risk factors or existing cardiovascular disease (CVD) are at increased risk of developing coronavirus disease 19 (COVID-19).
  • These patients often experience worse outcomes following COVID-19 infection.
  • Translating this knowledge into effective clinical practice remains a significant challenge.

Purpose of the Study:

  • To review current evidence on the relationship between cardiovascular therapies and COVID-19.
  • To determine if cardiovascular medications can reduce the likelihood of SARS-CoV-2 infection.
  • To assess if these therapies improve survival rates in patients with COVID-19.

Main Methods:

  • Systematic review of existing scientific literature.
  • Analysis of clinical data and observational studies.
  • Synthesis of evidence regarding cardiovascular disease and COVID-19 outcomes.

Main Results:

  • Evidence suggests a complex interplay between cardiovascular health and COVID-19 severity.
  • The impact of specific cardiovascular therapies on infection risk and patient survival is still under investigation.
  • Data highlights the critical need for tailored management strategies.

Conclusions:

  • Cardiovascular health is a critical factor in COVID-19 prognosis.
  • Further research is needed to clarify the role of cardiovascular therapies in managing COVID-19.
  • Practical recommendations are provided for cardiologists and infectious disease specialists managing these patients.

Keywords:
COVID-19CoronavirusSARS-CoV-2cardiovascularcomorbiditiesrisk factors

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.3K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.3K

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
270
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
779
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
281
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
528